Journal article icon

Journal article

Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation

Abstract:
Background: Inflammation is a key driver of atherosclerosis, yet the mechanisms sustaining inflammation in human plaques remain poorly understood. This study uses a network-based approach to identify immune gene programs involved in the transition from low- to high-risk (rupture-prone) human atherosclerotic plaques. Methods: Expression data from human carotid artery plaques, both stable (low-risk, n = 16) and unstable (high-risk, n = 27), were analyzed using Weighted Gene Co-expression Network Analysis (WGCNA). Bayesian network inference, operated on the eigengene values from the WGCNA, further extended the WGCNA analysis, and similarity to the signature of T cell subsets was validated in single-cell RNA sequencing data of human plaques, and a loss-of-function study in a mouse model of atherosclerosis. In silico drug repurposing was performed to identify potential therapeutic targets. Results: Our analysis revealed a distinct gene module with a prominent T cell signature, particularly in unstable plaques. Key regulatory factors, RUNX3, IRF7 and in particular PRDM1, were significantly downregulated in plaque T cells from symptomatic versus asymptomatic patients, indicating a protective role. Additionally, as PRDM1 is downstream of IRF7, we opted for PRDM1 as a key target. T cell-specific Prdm1 deficiency in Western-type diet fed Ldlr knockout mice featured accelerated plaque progression. Finally, as PRDM1 targeting drugs are not yet available, we performed in silico drug repurposing, identifying EGFR inhibitors as promising therapeutic candidates. Conclusions: This study highlights a PRDM1-regulated T cell network that distinguishes high-risk from low-risk plaques and demonstrates the regulatory role of T cell PRDM1 in controlling atherosclerosis, positioning this pathway as a promising therapeutic target.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13073-025-01541-6

Authors


More from this funder
Funder identifier:
https://ror.org/01czwga19
More from this funder
Funder identifier:
https://ror.org/04jsz6e67
More from this funder
Funder identifier:
https://ror.org/03zttf063
More from this funder
Funder identifier:
https://ror.org/00f3sc705
More from this funder
Funder identifier:
https://ror.org/052261q33


Publisher:
BioMed Central
Journal:
Genome Medicine More from this journal
Volume:
17
Issue:
1
Article number:
109
Publication date:
2025-10-02
Acceptance date:
2025-08-27
DOI:
EISSN:
1756994X
ISSN:
1756994X


Language:
English
Keywords:
Source identifiers:
3337531
Deposit date:
2025-10-02
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP